{"id":"W2512686635","doi":"10.1016/j.amjmed.2016.06.009","title":"Preclinical and Clinical Data for Factor Xa and “Universal” Reversal Agents","year":2016,"lang":"en","type":"review","venue":"The American Journal of Medicine","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"CSL Behring; McMaster University; Pfizer; Daiichi Sankyo Europe; Bristol-Myers Squibb; National Heart, Lung, and Blood Institute; Boehringer Ingelheim","keywords":"Medicine; Clinical trial; Stroke (engine); Atrial fibrillation; Intensive care medicine; Venous thromboembolism; Clotting factor; Rivaroxaban; Pharmacology; Internal medicine; Warfarin; Thrombosis","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009639555,0.0007790531,0.001460781,0.002095922,0.0002329359,0.001105657,0.0009573746,0.001097429,0.008165435],"category_scores_gemma":[0.002152733,0.0002497761,0.001299328,0.001640867,0.0003432102,0.001025497,0.0005635711,0.001430864,0.002177521],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003651708,"about_ca_system_score_gemma":0.001110396,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006315197,"about_ca_topic_score_gemma":0.001056365,"domain_scores_codex":[0.9996141,0.00006609603,0.00008963267,0.00005905292,0.0001476093,0.00002353126],"domain_scores_gemma":[0.9990337,0.0005402568,0.0001425274,0.00002466036,0.0002135674,0.00004527593],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002633502,0.0001709934,0.0002952827,0.0994054,0.0003407031,0.000309293,0.0001033035,0.0003272563,0.002931029,0.003074504,0.02823884,0.86454],"study_design_scores_gemma":[0.00007851345,0.0003625046,0.001180683,0.02091204,0.0008904562,0.001838297,0.00007597842,0.00009572913,0.001114483,0.001372387,0.9720496,0.00002935857],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001835482,0.9983058,0.00007707102,0.0001789495,0.0001369516,0.0000100779,0.00004645453,0.000004733669,0.001056379],"genre_scores_gemma":[0.001101157,0.9979998,0.0001676913,0.0002031009,0.0001034172,0.00001182433,0.00006049965,0.000001486095,0.0003509284],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.008165435,"threshold_uncertainty_score":0.02731615,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.4495709884057138,"score_gpt":0.5475550975930008,"score_spread":0.097984109187287,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}